Biocon's win raises hopes for other Indian pharma companies—some already sell biosimilars in India, including Dr Reddy's Laboratories, Torrent ... Biocon collaborated with Dutch company Mylan NV to develop its biosimilar Trastuzumab, which is sold as Herceptin by the current intellectual property ...
Read more: US FDA Approval for Us Holds Bigger Promise: Kiran Mazumdar-Shaw's Biocon